NO953457D0 - Somatostatinpeptider, fremgangsmåte for deres fremstilling, farmasöytiske preparater derav og anvendelse - Google Patents

Somatostatinpeptider, fremgangsmåte for deres fremstilling, farmasöytiske preparater derav og anvendelse

Info

Publication number
NO953457D0
NO953457D0 NO953457A NO953457A NO953457D0 NO 953457 D0 NO953457 D0 NO 953457D0 NO 953457 A NO953457 A NO 953457A NO 953457 A NO953457 A NO 953457A NO 953457 D0 NO953457 D0 NO 953457D0
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical preparations
somatostatin peptides
somatostatin
peptides
Prior art date
Application number
NO953457A
Other languages
English (en)
Other versions
NO953457L (no
NO316569B1 (no
Inventor
Rainer Albert
Christian Bruns
Peter Smith-Jones
Barbara Stolz
Gisbert Weckbecker
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO953457D0 publication Critical patent/NO953457D0/no
Publication of NO953457L publication Critical patent/NO953457L/no
Publication of NO316569B1 publication Critical patent/NO316569B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO953457A 1994-09-06 1995-09-04 Somatostatinpeptider, farmasøytiske preparater derav, og anvendelse derav, kit for anvendelse ved behandling av somatostatinreseptorpositiv tumorinvasivitet eller symptomer forbundet med tumorvekst, samt farmasøytisk preparat for samme formål NO316569B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9417873A GB9417873D0 (en) 1994-09-06 1994-09-06 Organic compounds

Publications (3)

Publication Number Publication Date
NO953457D0 true NO953457D0 (no) 1995-09-04
NO953457L NO953457L (no) 1996-03-07
NO316569B1 NO316569B1 (no) 2004-02-23

Family

ID=10760870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953457A NO316569B1 (no) 1994-09-06 1995-09-04 Somatostatinpeptider, farmasøytiske preparater derav, og anvendelse derav, kit for anvendelse ved behandling av somatostatinreseptorpositiv tumorinvasivitet eller symptomer forbundet med tumorvekst, samt farmasøytisk preparat for samme formål

Country Status (31)

Country Link
US (2) US6183721B1 (no)
EP (1) EP0714911B1 (no)
JP (1) JP3054346B2 (no)
KR (1) KR100364111B1 (no)
CN (1) CN1185252C (no)
AT (1) ATE199561T1 (no)
AU (1) AU703057B2 (no)
BR (1) BR9503936A (no)
CA (1) CA2157530C (no)
CO (1) CO4410344A1 (no)
CZ (1) CZ287012B6 (no)
DE (1) DE69520256T2 (no)
DK (1) DK0714911T3 (no)
ES (1) ES2157309T3 (no)
FI (1) FI117424B (no)
GB (1) GB9417873D0 (no)
GR (1) GR3035997T3 (no)
HU (1) HU218284B (no)
IL (1) IL115154A (no)
NO (1) NO316569B1 (no)
NZ (1) NZ272919A (no)
PE (1) PE41496A1 (no)
PL (1) PL182434B1 (no)
PT (1) PT714911E (no)
RU (1) RU2156774C2 (no)
SG (1) SG50356A1 (no)
SI (1) SI0714911T1 (no)
SK (1) SK283774B6 (no)
TR (1) TR199501094A2 (no)
TW (1) TW387898B (no)
ZA (1) ZA957475B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
AT405906B (de) * 1997-03-14 1999-12-27 Irene Dr Virgolini Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie
US6358491B1 (en) 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
LT3351246T (lt) 2001-02-19 2019-07-10 Novartis Pharma Ag Rapamicino darinys, skirtas kieto naviko, susijusio su nereguliuojama angiogeneze, gydymui
IL157359A0 (en) * 2001-02-26 2004-02-19 Bristol Myers Squibb Pharma Co A radiopharmaceutical composition containing an ascorbic acid analog
ITMI20011708A1 (it) * 2001-08-03 2003-02-03 Bracco Imaging Spa Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
AU2003250658B2 (en) 2002-07-18 2009-07-16 Helix Biopharma Corp. Use of urease for inhibiting cancer cell growth
WO2004081031A2 (en) * 2003-03-10 2004-09-23 Biogen Idec Inc. Thiol-mediated drug attachment to targeting peptides
EP1771205B1 (en) 2004-06-18 2016-10-26 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
US20100029911A1 (en) * 2004-11-24 2010-02-04 Aplagen Gmbh Method For Solid-Phase Peptide Synthesis And Purification
CA2699394C (en) 2007-09-17 2020-03-24 The Regents Of The University Of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
US20140170068A1 (en) 2011-03-11 2014-06-19 Board Of Regents Of The University Of Nebraska Biomarker for coronary artery disease
US9480759B2 (en) 2012-11-21 2016-11-01 Serene, Llc Tin-117m somatostatin receptor binding compounds and methods
CN103275189B (zh) * 2013-06-06 2014-08-06 深圳翰宇药业股份有限公司 一种用于肽树脂的裂解液及其在固相裂解合成生长抑素中的应用
CA3006759A1 (en) 2015-11-30 2017-06-08 The Regents Of The University Of California Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen
WO2018044812A2 (en) 2016-08-29 2018-03-08 Fred Hutchinson Cancer Research Center Chelating platform for delivery of radionuclides
US12049511B2 (en) 2016-11-10 2024-07-30 Fortis Therapeutics, Inc. Engineered CD46-specific effector cells and uses thereof in the treatment of cancer
ES2960030T3 (es) 2017-01-12 2024-02-29 Radiomedix Inc Tratamiento de células cancerosas que sobreexpresan receptores de somatostatina utilizando derivados de ocreótido quelados con radioisótopos
TW202017600A (zh) * 2018-06-21 2020-05-16 法商艾普森藥品公司 用於放射性醫藥之含有體抑素類似物之組成物
TW202015744A (zh) 2018-06-21 2020-05-01 法商艾普森藥品公司 用於放射性醫藥之含有體抑素類似物之組成物
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US10596278B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
CA3188728A1 (en) 2020-08-07 2022-02-10 Marc Nasoff Immunoconjugates targeting cd46 and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006643A (en) 1987-06-24 1991-04-09 The Dow Chemical Company Process for preparing isothiocyanato functionalized metal complexes
DE3728600A1 (de) 1987-08-27 1989-03-09 Hoechst Ag Verfahren zur markierung von substanzen mit technetium oder rhenium
AU630362B2 (en) * 1988-05-25 1992-10-29 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Macrocyclic chelates & methods of use thereof
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
CA2066031C (en) 1989-09-29 2001-02-27 Mary A. Gray Methods for reducing non-target retention of immunoconjugates and metabolites thereof
WO1993018797A1 (en) * 1992-03-25 1993-09-30 Mallinckrodt Medical, Inc. Method of intraoperatively detecting and locating tumoral tissues
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
CA2113121A1 (en) * 1993-01-12 1994-07-13 Rainer Albert Peptides
EP0738158B1 (en) * 1994-01-12 2002-04-03 Amersham plc Biological targeting agents
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
PL182434B1 (pl) 2002-01-31
CA2157530A1 (en) 1996-03-07
HU218284B (en) 2000-07-28
TR199501094A2 (tr) 1996-06-21
AU703057B2 (en) 1999-03-11
GR3035997T3 (en) 2001-09-28
US6183721B1 (en) 2001-02-06
FI117424B (fi) 2006-10-13
ES2157309T3 (es) 2001-08-16
SK283774B6 (sk) 2004-01-08
CN1127259A (zh) 1996-07-24
PE41496A1 (es) 1996-10-14
PL310274A1 (en) 1996-03-18
CO4410344A1 (es) 1997-01-09
SI0714911T1 (en) 2001-08-31
PT714911E (pt) 2001-08-30
CA2157530C (en) 2007-04-03
TW387898B (en) 2000-04-21
ZA957475B (en) 1997-03-06
RU2156774C2 (ru) 2000-09-27
CZ226395A3 (en) 1996-03-13
KR100364111B1 (ko) 2003-02-05
DK0714911T3 (da) 2001-07-09
FI954147A (fi) 1996-03-07
JPH0881498A (ja) 1996-03-26
NO953457L (no) 1996-03-07
SK108895A3 (en) 1996-06-05
IL115154A0 (en) 1995-12-31
GB9417873D0 (en) 1994-10-26
DE69520256D1 (de) 2001-04-12
NO316569B1 (no) 2004-02-23
FI954147A0 (fi) 1995-09-04
CZ287012B6 (en) 2000-08-16
KR960010683A (ko) 1996-04-20
DE69520256T2 (de) 2001-08-09
HU9502577D0 (en) 1995-11-28
ATE199561T1 (de) 2001-03-15
SG50356A1 (en) 2000-11-21
NZ272919A (en) 1996-12-20
EP0714911B1 (en) 2001-03-07
EP0714911A2 (en) 1996-06-05
IL115154A (en) 2000-08-13
US6277356B1 (en) 2001-08-21
CN1185252C (zh) 2005-01-19
EP0714911A3 (en) 1996-08-21
AU3041495A (en) 1996-03-21
BR9503936A (pt) 1996-09-24
HUT72895A (en) 1996-06-28
JP3054346B2 (ja) 2000-06-19

Similar Documents

Publication Publication Date Title
NO953457L (no) Somatostatinpeptider, fremgangsmåte for deres fremstilling, farmasöytiske preparater derav og anvendelse
DK290986D0 (da) 2-arylimidazolforbindelser, laegemidler indeholdende disse forbindelser og deres fremstilling
DK362787D0 (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK231687D0 (da) Heterocykliske forbindelser, deres fremstilling og anvendelse, samt laegemidler indeholdende disse forbindelser
DK165693C (da) 2-(n-substitueret guanidino)-4-heteroarylthiazol-forbindelser og farmaceutiske praeparater indeholdende disse
DK610284A (da) 2-phenyl-imidazolderivater, deres fremstilling og laegemidler indeholdende disse forbindelser
DK195087A (da) Heterocyclisk og alkansulfonamidophenyl-substituerede aminer og deres anvendelse til fremstilling af antiarrytmiske laegemidler samt farmaceutiske praeparater indeholdende disse forbindelser
DK166279C (da) 3,4-dihydro-2h-benzooebaapyranderivater, deres fremstilling og laegemidler indeholdende disse forbindelser
DK162892C (da) 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
DE3688087D1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DK457787D0 (da) Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK90189A (da) Trisubstituerede aminer, fremgangsmaade til deres fremstilling samt laegemidler indeholdende disse forbindelser
NO933558D0 (no) Benzimidazoler, legemidler inneholdende disse forbindelser, og fremgangsmaate for deres fremstilling
DK512185D0 (da) 3,4-diazolderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
DK189786D0 (da) 4-aminoalkylidensubstituerede 3-aryl-5(4h)-isoxazoloner, fremgangsmaader til fremstilling deraf, samt laegemidler indeholdende disse forbindelser og deres anvendelse
DK141784A (da) Penemforbindelser, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
NO940533D0 (no) Rensede streptograminer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
DK127086A (da) Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
GB8819545D0 (en) New benzazole derivatives processes for their preparation & pharmaceutical preparations containing such compounds & use thereof
DK26591A (da) Cytidin-5'-diphosphatalkanoler og -glyceroler, fremgangsmaade til fremstilling heraf og praeparater indeholdende disse forbindelser
DK162228C (da) Substituerede 7-aminocarbonyloxy-2,3,4,5-tetrahydro-1h-3-benzazepiner, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne

Legal Events

Date Code Title Description
MK1K Patent expired